Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Sickle Cell Disease Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Sickle Cell Disease Drugmarket, defines the market attractiveness level of Sickle Cell Disease Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Sickle Cell Disease Drug industry, describes the types of Sickle Cell Disease Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Sickle Cell Disease Drug market and the development prospects and opportunities of Sickle Cell Disease Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Sickle Cell Disease Drug market in Chapter 13.
By Player:
Gilead Sciences Inc
Bioverativ Inc
CRISPR Therapeutics
Global Blood Therapeutics Inc
ArQule Inc
Bio Products Laboratory Ltd
bluebird bio Inc
Genethon SA
Bristol-Myers Squibb Co
Addmedica SAS
Acceleron Pharma Inc
Gamida Cell Ltd
Annexin Pharmaceuticals AB
Daiichi Sankyo Co Ltd
Errant Gene Therapeutics LLC
Editas Medicine Inc
Angiocrine Bioscience Inc
CSL Ltd
Calimmune Inc
By Type:
ARQ-092
BIVV-003
CAL-H
CTX-001
DRX-194
Others
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Sickle Cell Disease Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Sickle Cell Disease Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Sickle Cell Disease Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Sickle Cell Disease Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Sickle Cell Disease Drug Market Analysis and Outlook to 2022
-
7.1 Global Sickle Cell Disease Drug Consumption (2017-2022)
-
7.2 United States Sickle Cell Disease Drug Consumption (2017-2022)
-
7.3 Europe Sickle Cell Disease Drug Consumption (2017-2022)
-
7.4 China Sickle Cell Disease Drug Consumption (2017-2022)
-
7.5 Japan Sickle Cell Disease Drug Consumption (2017-2022)
-
7.6 India Sickle Cell Disease Drug Consumption (2017-2022)
-
7.7 South Korea Sickle Cell Disease Drug Consumption (2017-2022)
8 Region and Country-wise Sickle Cell Disease Drug Market Analysis and Outlook to 2028
-
8.1 Global Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
8.2 United States Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
8.3 Europe Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
8.4 China Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
8.5 Japan Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
8.6 India Sickle Cell Disease Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Sickle Cell Disease Drug Consumption Forecast (2022-2028)
9 Global Sickle Cell Disease Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Sickle Cell Disease Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global ARQ-092 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global BIVV-003 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global CAL-H Consumption and Growth Rate (2017-2022)
-
9.1.4 Global CTX-001 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global DRX-194 Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Sickle Cell Disease Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Sickle Cell Disease Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Sickle Cell Disease Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global ARQ-092 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global BIVV-003 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global CAL-H Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global CTX-001 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global DRX-194 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Sickle Cell Disease Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Sickle Cell Disease Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Sickle Cell Disease Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Sickle Cell Disease Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Sickle Cell Disease Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Sickle Cell Disease Drug Market Competitive Analysis
-
14.1 Gilead Sciences Inc
-
14.1.1 Gilead Sciences Inc Company Details
-
14.1.2 Gilead Sciences Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Gilead Sciences Inc Sickle Cell Disease Drug Product and Service
-
14.2 Bioverativ Inc
-
14.2.1 Bioverativ Inc Company Details
-
14.2.2 Bioverativ Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bioverativ Inc Sickle Cell Disease Drug Product and Service
-
14.3 CRISPR Therapeutics
-
14.3.1 CRISPR Therapeutics Company Details
-
14.3.2 CRISPR Therapeutics Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 CRISPR Therapeutics Sickle Cell Disease Drug Product and Service
-
14.4 Global Blood Therapeutics Inc
-
14.4.1 Global Blood Therapeutics Inc Company Details
-
14.4.2 Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Global Blood Therapeutics Inc Sickle Cell Disease Drug Product and Service
-
14.5 ArQule Inc
-
14.5.1 ArQule Inc Company Details
-
14.5.2 ArQule Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 ArQule Inc Sickle Cell Disease Drug Product and Service
-
14.6 Bio Products Laboratory Ltd
-
14.6.1 Bio Products Laboratory Ltd Company Details
-
14.6.2 Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bio Products Laboratory Ltd Sickle Cell Disease Drug Product and Service
-
14.7 bluebird bio Inc
-
14.7.1 bluebird bio Inc Company Details
-
14.7.2 bluebird bio Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 bluebird bio Inc Sickle Cell Disease Drug Product and Service
-
14.8 Genethon SA
-
14.8.1 Genethon SA Company Details
-
14.8.2 Genethon SA Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Genethon SA Sickle Cell Disease Drug Product and Service
-
14.9 Bristol-Myers Squibb Co
-
14.9.1 Bristol-Myers Squibb Co Company Details
-
14.9.2 Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Bristol-Myers Squibb Co Sickle Cell Disease Drug Product and Service
-
14.10 Addmedica SAS
-
14.10.1 Addmedica SAS Company Details
-
14.10.2 Addmedica SAS Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Addmedica SAS Sickle Cell Disease Drug Product and Service
-
14.11 Acceleron Pharma Inc
-
14.11.1 Acceleron Pharma Inc Company Details
-
14.11.2 Acceleron Pharma Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Acceleron Pharma Inc Sickle Cell Disease Drug Product and Service
-
14.12 Gamida Cell Ltd
-
14.12.1 Gamida Cell Ltd Company Details
-
14.12.2 Gamida Cell Ltd Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Gamida Cell Ltd Sickle Cell Disease Drug Product and Service
-
14.13 Annexin Pharmaceuticals AB
-
14.13.1 Annexin Pharmaceuticals AB Company Details
-
14.13.2 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Product and Service
-
14.14 Daiichi Sankyo Co Ltd
-
14.14.1 Daiichi Sankyo Co Ltd Company Details
-
14.14.2 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Product and Service
-
14.15 Errant Gene Therapeutics LLC
-
14.15.1 Errant Gene Therapeutics LLC Company Details
-
14.15.2 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Product and Service
-
14.16 Editas Medicine Inc
-
14.16.1 Editas Medicine Inc Company Details
-
14.16.2 Editas Medicine Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Editas Medicine Inc Sickle Cell Disease Drug Product and Service
-
14.17 Angiocrine Bioscience Inc
-
14.17.1 Angiocrine Bioscience Inc Company Details
-
14.17.2 Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 Angiocrine Bioscience Inc Sickle Cell Disease Drug Product and Service
-
14.18 CSL Ltd
-
14.18.1 CSL Ltd Company Details
-
14.18.2 CSL Ltd Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.18.3 CSL Ltd Sickle Cell Disease Drug Product and Service
-
14.19 Calimmune Inc
-
14.19.1 Calimmune Inc Company Details
-
14.19.2 Calimmune Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.19.3 Calimmune Inc Sickle Cell Disease Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Sickle Cell Disease Drug
-
Figure Sickle Cell Disease Drug Picture
-
Table Global Sickle Cell Disease Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Sickle Cell Disease Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Sickle Cell Disease Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Sickle Cell Disease Drug Consumption by Country (2017-2022)
-
Figure United States Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure China Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure India Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Sickle Cell Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Sickle Cell Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Sickle Cell Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ARQ-092 Consumption and Growth Rate (2017-2022)
-
Figure Global BIVV-003 Consumption and Growth Rate (2017-2022)
-
Figure Global CAL-H Consumption and Growth Rate (2017-2022)
-
Figure Global CTX-001 Consumption and Growth Rate (2017-2022)
-
Figure Global DRX-194 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global ARQ-092 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BIVV-003 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CAL-H Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CTX-001 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global DRX-194 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Sickle Cell Disease Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Sickle Cell Disease Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Gilead Sciences Inc (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Inc Sickle Cell Disease Drug Product and Service
-
Table Bioverativ Inc (Foundation Year, Company Profile and etc.)
-
Table Bioverativ Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bioverativ Inc Sickle Cell Disease Drug Product and Service
-
Table CRISPR Therapeutics (Foundation Year, Company Profile and etc.)
-
Table CRISPR Therapeutics Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table CRISPR Therapeutics Sickle Cell Disease Drug Product and Service
-
Table Global Blood Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Global Blood Therapeutics Inc Sickle Cell Disease Drug Product and Service
-
Table ArQule Inc (Foundation Year, Company Profile and etc.)
-
Table ArQule Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table ArQule Inc Sickle Cell Disease Drug Product and Service
-
Table Bio Products Laboratory Ltd (Foundation Year, Company Profile and etc.)
-
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Product and Service
-
Table bluebird bio Inc (Foundation Year, Company Profile and etc.)
-
Table bluebird bio Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table bluebird bio Inc Sickle Cell Disease Drug Product and Service
-
Table Genethon SA (Foundation Year, Company Profile and etc.)
-
Table Genethon SA Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genethon SA Sickle Cell Disease Drug Product and Service
-
Table Bristol-Myers Squibb Co (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Product and Service
-
Table Addmedica SAS (Foundation Year, Company Profile and etc.)
-
Table Addmedica SAS Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Addmedica SAS Sickle Cell Disease Drug Product and Service
-
Table Acceleron Pharma Inc (Foundation Year, Company Profile and etc.)
-
Table Acceleron Pharma Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Acceleron Pharma Inc Sickle Cell Disease Drug Product and Service
-
Table Gamida Cell Ltd (Foundation Year, Company Profile and etc.)
-
Table Gamida Cell Ltd Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gamida Cell Ltd Sickle Cell Disease Drug Product and Service
-
Table Annexin Pharmaceuticals AB (Foundation Year, Company Profile and etc.)
-
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Product and Service
-
Table Daiichi Sankyo Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Product and Service
-
Table Errant Gene Therapeutics LLC (Foundation Year, Company Profile and etc.)
-
Table Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Errant Gene Therapeutics LLC Sickle Cell Disease Drug Product and Service
-
Table Editas Medicine Inc (Foundation Year, Company Profile and etc.)
-
Table Editas Medicine Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Editas Medicine Inc Sickle Cell Disease Drug Product and Service
-
Table Angiocrine Bioscience Inc (Foundation Year, Company Profile and etc.)
-
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Product and Service
-
Table CSL Ltd (Foundation Year, Company Profile and etc.)
-
Table CSL Ltd Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Ltd Sickle Cell Disease Drug Product and Service
-
Table Calimmune Inc (Foundation Year, Company Profile and etc.)
-
Table Calimmune Inc Sickle Cell Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Calimmune Inc Sickle Cell Disease Drug Product and Service
-
